Phenyllactic acid
|
Basic information |
| Metabolite name | Phenyllactic acid |
 | HMDB0000779 |
 |
C01479 |
 |
3848 |
| Synonyms | DL-3-Phenyllactic acid |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | Phenyllactic acid |
| HMDB0000779 |
|
C01479 |
|
3848 |
| Synonyms | DL-3-Phenyllactic acid |
| No. of studies | 4 |
|
Relationship between Phenyllactic acid and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M104 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M104 | Type2 | CUMS + fluoxetine group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M104 | Type2 | CUMS + ZB group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M104 | Type2 | CUMS + BH group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M1047 | Type2 | CSDS + 3,4-methylenedioxymethamphetamine group vs. CSDS group | Plasma | C57BL/6 mouse | Down |
| Study M512 | Type1 | CUMS group vs. control group | Urine | Goto-Kakizaki rat | Up |
| Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Down |